Overview and definition
Hypoparathyroidism is a rare metabolic endocrine disorder characterized by deficient or absent parathyroid hormone (PTH) secretion, resulting in hypocalcemia, hyperphosphatemia, and low levels of 1,25-dihydroxyvitamin D.[1][2] PTH is the primary regulator of extracellular calcium homeostasis through its actions on bone, kidney, and intestine; its deficiency leads to reduced bone remodeling with increased bone mass, impaired renal calcium reabsorption, and ectopic soft-tissue calcifications.[1][2] The most common etiology is iatrogenic injury to or removal of the parathyroid glands during anterior neck surgery, accounting for approximately 78% of cases.[1][3] Nonsurgical causes include autoimmune destruction, genetic disorders (isolated or syndromic), infiltrative diseases, and mineral deposition disorders.[3][4] Dental and skeletal manifestations—including enamel hypoplasia, hypodontia, eruption disturbances, and increased bone density in the jaws—may be the presenting or incidental findings on dental radiographs.[1][5] Management centers on calcium and active vitamin D supplementation, with PTH replacement therapy reserved for refractory cases.[1][4]
Terminology and classification
The accepted term is hypoparathyroidism, which encompasses all forms of PTH deficiency regardless of etiology.[1][2]
- Postsurgical (iatrogenic) hypoparathyroidism: PTH deficiency resulting from damage to or removal of parathyroid glands during thyroidectomy, parathyroidectomy, or other anterior neck surgery.[3][6]
- Transient postsurgical hypoparathyroidism lasts less than 6 months; chronic (permanent) postsurgical hypoparathyroidism persists beyond 6 months.[6]
- Nonsurgical hypoparathyroidism: Previously termed "idiopathic hypoparathyroidism" when no cause was identified; now subdivided into autoimmune, genetic, infiltrative, and other etiologies.[7][8]
- Autosomal dominant hypocalcemia type 1 (ADH1): A genetic form caused by activating mutations of the calcium-sensing receptor (CaSR), resulting in decreased PTH secretion and renal calcium wasting.[1]
- Pseudohypoparathyroidism (PHP): A distinct entity characterized by end-organ resistance to PTH rather than PTH deficiency; PTH levels are elevated. PHP should not be confused with true hypoparathyroidism, though both share dental and calcification findings.[5][9]
Epidemiology
Hypoparathyroidism has an estimated prevalence of 23 to 37 per 100,000 person-years.[1][6] Postsurgical hypoparathyroidism predominates, with transient hypocalcemia occurring in 20–30% and permanent hypoparathyroidism in 1–7% of patients after total thyroidectomy.[3] Because thyroid surgery is more common in women, postsurgical hypoparathyroidism is seen more frequently in older adult females.[1] Nonsurgical forms, including autoimmune and genetic etiologies, account for the remaining cases and tend to present earlier in life.[3][7] Autoimmune destruction is the most common nonsurgical cause.[3] Genetic forms—including chromosome 22q11.2 deletion syndrome (DiGeorge syndrome), autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED), and CaSR-activating mutations—may present in childhood.[1][10] Dental abnormalities are primarily reported in nonsurgical hypoparathyroidism, where the metabolic disturbance is present during odontogenesis.[1][5]
Clinical presentation
Neuromuscular manifestations
The hallmark clinical features result from hypocalcemia-induced neuromuscular irritability:[1][3]
- Paresthesias (perioral, fingertips) and muscle cramps are the most common symptoms
- Carpopedal spasm, Chvostek sign, and Trousseau sign
- Severe manifestations include laryngospasm, seizures, and cardiac arrhythmias (prolonged QTc interval)[1][6]
- Some patients with mild or chronic hypocalcemia, particularly genetic forms, may be asymptomatic[1]
Oral and dental findings
Dental abnormalities are characteristic of nonsurgical hypoparathyroidism when PTH deficiency is present during tooth development:[1][5]
- Enamel hypoplasia and enamel opacities are the most frequently reported dental findings, reflecting disrupted amelogenesis during hypocalcemia[5]
- Hypodontia (congenitally missing teeth)[1][5]
- Eruption disturbances, including delayed eruption of permanent teeth[5]
- Short or blunted roots and deviation of root morphology, particularly reported in pseudohypoparathyroidism[5]
- Postsurgical hypoparathyroidism typically does not produce dental developmental anomalies because tooth formation is complete before the onset of disease in adults
Systemic complications
- Basal ganglia calcification: reported in more than 50% of patients across etiologies, thought to be mediated by chronic hyperphosphatemia[1][11]
- Cataracts: a feature of long-standing nonsurgical disease[1]
- Renal complications: nephrocalcinosis, nephrolithiasis, and renal insufficiency, often related to therapy[1][12]
- Neuropsychiatric symptoms: fatigue, cognitive impairment ("brain fog"), depression[1]
- Ectopic calcifications in soft tissues including kidney, brain, vasculature, and skin[2][13]
Radiographic findings
The dental radiographic findings of hypoparathyroidism reflect two pathophysiologic processes: (1) the skeletal effects of chronically reduced bone remodeling, and (2) the developmental dental effects of hypocalcemia during odontogenesis. The former is seen in all forms; the latter is limited to nonsurgical hypoparathyroidism with onset during tooth development.[1][5][14]
Bone density and trabecular pattern
- The characteristic skeletal finding is increased bone density (osteosclerosis) throughout the skeleton, including the jaws, reflecting the absence of PTH-mediated bone resorption and profoundly reduced bone turnover[2][14][15]
- On dental radiographs, the jaws may appear diffusely radiopaque with a dense, homogeneous trabecular pattern[14][15]
- Bone mineral density is increased at all skeletal sites, with the greatest increases at the lumbar spine; the jaws follow this generalized pattern[15]
Lamina dura
- Thickened, prominent lamina dura around the teeth is a characteristic finding, representing the opposite of the lamina dura loss seen in hyperparathyroidism[14]
- This finding reflects the low bone turnover state with reduced osteoclastic resorption at the alveolar bone–periodontal ligament interface
Effects on teeth
Dental developmental anomalies are seen in nonsurgical hypoparathyroidism when the metabolic disturbance coincides with odontogenesis:[1][5]
- Enamel hypoplasia: the most consistently reported dental finding; appears as thin, irregular, or pitted enamel with reduced radiopacity of the crown. The pattern of involvement corresponds to the chronology of tooth development and the timing of hypocalcemia[5][16]
- Enamel opacities: areas of altered mineralization within otherwise normal-thickness enamel[5]
- Hypodontia: congenitally absent teeth, reported in nonsurgical hypoparathyroidism[1][5]
- Short or blunted roots: truncated root development, particularly reported in pseudohypoparathyroidism; may also occur in nonsurgical hypoparathyroidism[5]
- Delayed eruption: failure of permanent teeth to erupt at the expected chronologic age, with retained primary teeth[5]
- Widened pulp chambers: occasionally reported, reflecting disrupted dentinogenesis
Ectopic calcifications visible on dental imaging
- Basal ganglia calcifications may be incidentally detected on panoramic radiographs or CBCT as bilateral symmetric radiopacities projected over the temporal regions[1][11][13]
- Calcifications may extend beyond the basal ganglia to involve the cerebellum, subcortical white matter, and other brain regions[9][11]
- Soft-tissue calcifications in the cervical region (e.g., stylohyoid ligament, carotid artery) may occasionally be visible on panoramic radiographs[2][13]
Distribution and laterality
- Skeletal changes are bilateral and symmetric, affecting both jaws diffusely[14][15]
- Dental developmental anomalies follow a chronologic pattern: teeth developing during the period of active hypocalcemia are affected, while teeth that completed formation before disease onset are spared[5][16]
Recognized variants
- In 22q11.2 deletion syndrome (DiGeorge syndrome), dental findings include enamel hypoplasia, delayed eruption, and hypodontia in addition to the characteristic craniofacial features[10][17]
- In pseudohypoparathyroidism, root morphology deviations and eruption disturbances are prominent; shortened metacarpals (brachydactyly) on hand radiographs are a diagnostic clue[5][18]
Other imaging findings
Head CT
- Basal ganglia calcification is the most characteristic cross-sectional imaging finding, appearing as bilateral symmetric hyperdense foci in the globus pallidus, caudate, putamen, and dentate nuclei of the cerebellum. In a case-control study of 142 patients with chronic hypoparathyroidism, 25.4% had basal ganglia calcification on CT, developing at a younger age than in controls; calcification was 5.1-fold more common in nonsurgical than postsurgical patients.[11][13]
- The extent of calcification correlates with lower serum calcium and lower calcium-to-phosphate ratio. There is no evidence that calcification regresses with conventional treatment.[11][13]
Renal imaging
- Nephrocalcinosis and nephrolithiasis are common complications, identified on ultrasound or CT. Renal calcifications were present in 22% of patients who underwent renal imaging in one cross-sectional study.[12]
Skeletal densitometry
- DXA demonstrates above-average bone mineral density at all sites, most pronounced at the lumbar spine. High-resolution peripheral quantitative CT shows increased cortical volumetric BMD with reduced cortical porosity, and more numerous but thinner trabeculae.[15]
Differential diagnosis
The dental radiographic findings of hypoparathyroidism—increased bone density, thickened lamina dura, enamel hypoplasia, and hypodontia—overlap with several metabolic, genetic, and developmental conditions. Correlation with serum calcium, phosphate, and PTH levels is essential for definitive diagnosis.
| Entity | Why it is considered | Best discriminator |
|---|---|---|
| Pseudohypoparathyroidism | Enamel hypoplasia, eruption disturbances, short roots, and basal ganglia calcifications mimicking true hypoparathyroidism | Elevated PTH levels, brachydactyly (shortened metacarpals), and [5][9]Albright hereditary osteodystrophy phenotype distinguish PHP[9][18] |
| Hyperparathyroidism (primary or secondary) | Metabolic bone disease affecting the jaws with altered lamina dura and trabecular pattern | Hyperparathyroidism produces loss of lamina dura, ground-glass osteopenia, and brown tumors—the radiographic opposite of hypoparathyroidism[14][19] |
| Amelogenesis imperfecta | Generalized enamel defects with thin, hypoplastic, or hypomineralized enamel on dental radiographs | Isolated dental finding without systemic hypocalcemia, hyperphosphatemia, or ectopic calcifications; genetic testing confirms[20][21] |
| Renal osteodystrophy | Altered jaw bone density, loss of lamina dura, and periapical radiolucencies in patients with chronic kidney disease | Elevated PTH (secondary hyperparathyroidism), renal failure, and characteristic "rugger jersey spine" distinguish from hypoparathyroidism[14][22] |
| Primary familial brain calcification (Fahr disease) | Bilateral basal ganglia calcifications on imaging | Normal calcium, phosphate, and PTH levels; genetic testing for SLC20A2, PDGFRB, or other causative genes differentiates from hypoparathyroidism[9][23] |
The highest-risk diagnostic pitfall is misidentifying pseudohypoparathyroidism as true hypoparathyroidism, as both share dental anomalies and basal ganglia calcifications; serum PTH measurement is the critical discriminator, being low or inappropriately normal in hypoparathyroidism and elevated in pseudohypoparathyroidism.[1][9]
Histopathology
Hypoparathyroidism is a clinical and biochemical diagnosis; tissue biopsy of the jaws or teeth is not routinely performed for diagnostic purposes. However, histologic findings in affected tissues are well characterized.
Parathyroid gland
- In autoimmune hypoparathyroidism, the parathyroid glands show lymphocytic infiltration and progressive destruction of parenchymal chief cells, with eventual replacement by fibrosis and adipose tissue. Autoantibodies against the calcium-sensing receptor (CaSR) have been identified in some patients, though these may cause functional suppression of PTH secretion without glandular destruction.[8][24]
- In postsurgical hypoparathyroidism, the glands are absent (removed) or devascularized.[3]
- The autoantigen NALP5, localized to the cytoplasm of parathyroid chief cells, has been identified as a target in APECED-associated hypoparathyroidism.[25]
Dental hard tissues
- Enamel hypoplasia corresponds histologically to reduced enamel matrix deposition during amelogenesis, with irregular, thin enamel and pitting. The defect pattern reflects the chronology of hypocalcemia relative to tooth development.[5][16]
- Dentin may show interglobular dentin (areas of unmineralized dentin matrix) when hypocalcemia is present during dentinogenesis.[16]
Bone
- Bone biopsy in hypoparathyroidism demonstrates profoundly reduced bone remodeling with decreased osteoblast and osteoclast activity, increased trabecular bone volume, and thickened cortices. Trabeculae are more numerous but thinner than normal. These histomorphometric findings correlate with the increased bone density observed radiographically.[15][26]
Radiologic-pathologic correlation
The increased radiopacity of the jaws and thickened lamina dura on dental radiographs directly reflect the histomorphometric finding of reduced bone turnover with net bone accrual.[15][26] Enamel hypoplasia visible radiographically as thin, irregular crowns corresponds to deficient enamel matrix formation during periods of hypocalcemia.[5][16]
Management and prognosis
Diagnosis and workup
- Hypoparathyroidism is confirmed by demonstrating hypocalcemia (low ionized or albumin-corrected calcium), hyperphosphatemia, and a low or inappropriately normal intact PTH level.[1][27]
- Additional laboratory assessment includes serum magnesium, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, renal function, and 24-hour urinary calcium.[27]
- In nonsurgical cases, evaluation for autoimmune, genetic, or syndromic etiologies is indicated. Genetic testing with targeted gene panels should be pursued, particularly in pediatric patients or those with syndromic features.[1][8]
Conventional therapy
- First-line treatment consists of oral calcium supplementation and active vitamin D (calcitriol or alfacalcidol) to maintain serum calcium near the low-normal range while minimizing hypercalciuria.[1][27]
- Vitamin D deficiency should be corrected, and magnesium abnormalities addressed.[27]
- Monitoring includes periodic measurement of serum calcium, phosphate, creatinine, and 24-hour urinary calcium to avoid complications of overtreatment.[1][6]